Friday, February 03, 2023 7:27:27 AM
Source: Dow Jones News
Sabela Ojea
Apple Inc. posted its first quarterly revenue decline in nearly four years as manufacturing disruptions in China curbed its ability to deliver premium iPhones. Shares of the iPhone maker fell 2.4% in after-hours trading on Thursday.
Amazon.com Inc. warned of a period of reduced growth and signaled the difficult economic environment is denting the performance of its cloud-computing business that's been a profit engine for the company, despite also beating Wall Street expectations for fourth-quarter sales. Shares of the ecommerce giant dived 4.7% in after-hours trading.
Alphabet Inc. reported its first drop in advertising revenue since the beginning of the pandemic in the fourth quarter. Shares of Google's parent dropped 3.4% in after-hours trading.
Magenta Therapeutics Inc. said it could be up for sale as part of review of strategic alternatives. Shares of the clinical-stage biotechnology company surged 47% in after-hours trading.
Clorox Co. reported better-than-expected profit in its fiscal second quarter as the consumer products company cut costs and adjusted prices to offset inflation. Shares increased 3.6% in after-hours trading.
Write to Sabela Ojea at sabela.ojea@wsj.com; @sabelaojeaguix
(END) Dow Jones Newswires
February 02, 2023 19:06 ET (00:06 GMT)
Copyright (c) 2023 Dow Jones & Company, Inc.
Recent MGTA News
- Form ARS - Annual Report to Security Holders • Edgar (US Regulatory) • 04/11/2024 08:10:48 PM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 04/11/2024 08:09:33 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 04/11/2024 08:05:49 PM
- Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] • Edgar (US Regulatory) • 04/01/2024 10:34:58 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/01/2024 10:21:23 PM
- Form S-8 - Securities to be offered to employees in employee benefit plans • Edgar (US Regulatory) • 03/21/2024 09:10:06 PM
- Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend] • Edgar (US Regulatory) • 03/21/2024 09:02:14 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 03/21/2024 08:07:40 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/21/2024 08:04:15 PM
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 02/14/2024 09:16:19 PM
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 02/09/2024 09:10:16 PM
- Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend] • Edgar (US Regulatory) • 02/07/2024 09:52:11 PM
- Form SC 13G - Statement of acquisition of beneficial ownership by individuals • Edgar (US Regulatory) • 02/02/2024 09:32:00 PM
- Form SC 13D - General statement of acquisition of beneficial ownership • Edgar (US Regulatory) • 01/31/2024 05:11:40 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/26/2024 09:46:18 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/26/2024 09:43:38 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/26/2024 09:41:24 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/24/2024 11:55:26 PM
- Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] • Edgar (US Regulatory) • 01/24/2024 10:26:56 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/22/2024 12:34:29 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/08/2024 01:02:01 PM
- Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend] • Edgar (US Regulatory) • 12/21/2023 10:08:45 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/21/2023 09:16:46 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/09/2023 09:09:41 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM